Our mission is to more efficiently identify new therapies for serious diseases with unmet medical need
The Vanderbilt Institute for Clinical and Translational Research (
VICTR) and the Accelerating Drug Discovery & Repurposing Incubator (ADDRI) leverage Vanderbilt resources to discover novel gene/disease associations and rapidly launch and execute drug development programs. ADDRI is a multidisciplinary think tank of experts in various therapeutic areas: Basic scientists, clinicians, clinical researchers, technology transfer, legal/regulatory, statistics, biomedical informatics, and information science.
